What is the latest ACCPL stock price?
The latest stored price for ACCPL is Rs 209.50 as of 2026-11-03.
gimli
ACCPL stock AI analysis
ACCPL Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
ACCRETION PHARMA LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available ACCPL price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹209.50
1W return
+13.24%
1M return
+3.05%
3M return
+21.80%
6M return
+92.82%
1Y return
+259.35%
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
61.24
Turnover
₹0.34 cr
Why it can matter in screens
- Momentum: ACCPL is above 50DMA, above 200DMA; RSI is 61.24.
- Returns: 1D +4.99%, 1W +13.24%, 1M +3.05%, 3M +21.80%, 1Y +259.35%.
- Trend levels: 52W high ₹220.00, 52W low ₹54.60, off high -4.77%.
- Liquidity: latest turnover is ₹0.34 cr; volume vs 20D is +0.99%.
- Valuation/profitability: PE n/a, PB n/a, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Quick Answers
Is ACCPL above its 50DMA and 200DMA?
ACCPL is above 50DMA, above 200DMA. The latest 50DMA is 200.06 and the latest 200DMA is 131.89.
What are ACCPL PE, ROE and ROCE?
ACCPL has PE n/a, ROE n/a, and ROCE n/a in Gimli's latest available snapshot.
How has ACCPL performed recently?
ACCPL has returned +3.05% over 1 month, +21.80% over 3 months, and +259.35% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
No recent data available.
Annual income statement
No recent data available.
Balance sheet
No recent data available.
Cash flow
No recent data available.
Shareholding Trend
No recent data available.
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 424,658.30 cr | 35.053345 | +15.50% | +3.72% |
| DIVISLAB | DIVI S LABORATORIES LTD | 267,167.60 cr | 91.684145 | +18.37% | +47.91% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 157,377.11 cr | 74.094685 | +16.87% | +28.16% |
| LAURUSLABS | LAURUS LABS LIMITED | 125,408.69 cr | 114.827348 | +21.77% | +138.16% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 124,833.39 cr | 27.818646 | +16.04% | +26.46% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 121,354.29 cr | 57.614911 | +22.62% | +7.87% |
| DRREDDY | DR. REDDY S LABORATORIES | 113,923.95 cr | 40.698752 | +7.80% | +14.41% |
| CIPLA | CIPLA LTD | 112,841.65 cr | 38.950805 | +8.80% | -7.58% |
Try these prompts
- Analyze ACCRETION PHARMA with valuation, momentum and industry peers
- Compare ACCPL with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare ACCPL with other Healthcare stocks
Data snapshot: 2026-11-03. Not investment advice.